Literature DB >> 16904238

Neurotensin and growth of normal and neoplastic tissues.

B Mark Evers1.   

Abstract

Neurotensin (NT) is a brain-gut tridecapeptide that functions as a neurotransmitter/neuromodulator in the central nervous system (CNS) and as an endocrine agent in the periphery. NT has numerous physiologic effects on multiple organs. This review will focus on the effects of NT as a trophic factor for normal and neoplastic tissues. In this regard, NT may act as an endocrine agent or, in some instances, in a paracrine and/or autocrine fashion. These effects appear to be mediated predominantly through the G protein-coupled high-affinity NT receptor. However, some of the trophic effects may also be through the other two receptor subtypes, particularly the NT receptor type 3, which belongs to a recently identified family of sorting receptors. The signaling pathways mediating the effects of NT are multiple but most appear to activate the ERK signaling pathway, which then activates downstream transcription factors, ultimately leading to proliferation. NT may be a useful agent to enhance the growth of normal tissues such as the small bowel mucosa during periods of gut disuse or disease and, finally, the selective targeting of NT receptor subtypes on certain cancers may offer a novel strategy in the armamentarium of cancer chemotherapeutics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16904238     DOI: 10.1016/j.peptides.2006.01.028

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  41 in total

1.  The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in rats.

Authors:  Elizabeth N Holly; Bree Ebrecht; Adam J Prus
Journal:  Eur Neuropsychopharmacol       Date:  2011-01-28       Impact factor: 4.600

2.  Effects of a diet with inulin-enriched pasta on gut peptides and gastric emptying rates in healthy young volunteers.

Authors:  Francesco Russo; Caterina Clemente; Michele Linsalata; Marisa Chiloiro; Antonella Orlando; Emanuele Marconi; Guglielmina Chimienti; Giuseppe Riezzo
Journal:  Eur J Nutr       Date:  2010-10-12       Impact factor: 5.614

3.  Characterization of promoter elements regulating the expression of the human neurotensin/neuromedin N gene.

Authors:  Xiaofu Wang; Pat Gulhati; Jing Li; Paul R Dobner; Heidi Weiss; Courtney M Townsend; B Mark Evers
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

4.  HMC-1 human mast cells synthesize neurotensin (NT) precursor, secrete bioactive NT-like peptide(s) and express NT receptor NTS1.

Authors:  David E Cochrane; Robert E Carraway; Kimberly Harrington; Melissa Laudano; Stephen Rawlings; Ross S Feldberg
Journal:  Inflamm Res       Date:  2011-09-17       Impact factor: 4.575

5.  PI3K p110α/Akt signaling negatively regulates secretion of the intestinal peptide neurotensin through interference of granule transport.

Authors:  Jing Li; Jun Song; Margaret G Cassidy; Piotr Rychahou; Marlene E Starr; Jianyu Liu; Xin Li; Garretson Epperly; Heidi L Weiss; Courtney M Townsend; Tianyan Gao; B Mark Evers
Journal:  Mol Endocrinol       Date:  2012-06-14

6.  Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome.

Authors:  Mikaël Agopiantz; Patricia Forgez; Jean-Matthieu Casse; Stéphanie Lacomme; Claire Charra-Brunaud; Isabelle Clerc-Urmès; Olivier Morel; Céline Bonnet; Jean-Louis Guéant; Jean-Michel Vignaud; Anne Gompel; Guillaume Gauchotte
Journal:  Virchows Arch       Date:  2017-08-24       Impact factor: 4.064

7.  Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.

Authors:  Xianyong Gui; Shuhong Liu; Yuchu Yan; Zuhua Gao
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

8.  Neurotensin, a novel target of Wnt/β-catenin pathway, promotes growth of neuroendocrine tumor cells.

Authors:  Ji Tae Kim; Chunming Liu; Yekaterina Y Zaytseva; Heidi L Weiss; Courtney M Townsend; B Mark Evers
Journal:  Int J Cancer       Date:  2014-08-14       Impact factor: 7.396

9.  A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours.

Authors:  Elisa García-Garayoa; Peter Bläuenstein; Alain Blanc; Veronique Maes; Dirk Tourwé; P August Schubiger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-09       Impact factor: 9.236

Review 10.  Inflammation and neuropeptides: the connection in diabetic wound healing.

Authors:  Leena Pradhan; Christoph Nabzdyk; Nicholas D Andersen; Frank W LoGerfo; Aristidis Veves
Journal:  Expert Rev Mol Med       Date:  2009-01-13       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.